These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 22975660)
1. The permanent improvement of proteinuria and renal failure with colchicine and enalapril in a leukemic patient with renal amyloidosis secondary to ankylosing spondylitis: a review of the literature. Paydas S; Paydas S; Balal M Am J Ther; 2013; 20(4):344-6. PubMed ID: 22975660 [TBL] [Abstract][Full Text] [Related]
2. Is colchicine therapy effective in all patients with secondary amyloidosis? Unverdi S; Inal S; Ceri M; Unverdi H; Batgi H; Tuna R; Ozturk MA; Guz G; Duranay M Ren Fail; 2013 Sep; 35(8):1071-4. PubMed ID: 23841746 [TBL] [Abstract][Full Text] [Related]
3. Permanent improvement of renal dysfunction and proteinuria with colchicine in a patient with tumoral amyloidosis and basal cell carcinoma. Balal M; Seyrek N; Karayaylali I; Paydaş S Ren Fail; 2003 Jul; 25(4):677-80. PubMed ID: 12911175 [TBL] [Abstract][Full Text] [Related]
4. [Nephrotic syndrome in familial Mediterranean fever--effect of colchicine therapy]. Højberg AS; Mertz H Ugeskr Laeger; 1995 Jul; 157(28):4035-7. PubMed ID: 7645081 [TBL] [Abstract][Full Text] [Related]
5. AA type renal amyloidosis secondary to FMF: a long-term follow-up in two patients. Aybal Kutlugün A; Yildirim T; Altindal M; Arici M; Yasavul U; Turgan C Ren Fail; 2010; 32(10):1230-2. PubMed ID: 20954987 [TBL] [Abstract][Full Text] [Related]
6. Complete remission of nephrotic syndrome in a woman with renal amyloidosis due to familial mediterranean fever. Heras M; Saiz A; Fernández-Reyes MJ; Molina Á; Astrid Rodríguez M; Callejas R Nefrologia; 2016; 36(3):331-2. PubMed ID: 26560399 [No Abstract] [Full Text] [Related]
7. Complete reversal of nephrotic syndrome secondary to amyloidosis with use of infliximab in a patient with inflammatory bowel disease and ankylosing spondylitis. Akdoğan MF; Gücün M; Denizli N; Güney M; Akdag I; Ozcan TB; Duranay M Ren Fail; 2011; 33(5):531-3. PubMed ID: 21574898 [TBL] [Abstract][Full Text] [Related]
8. Regression of reactive systemic amyloidosis due to ankylosing spondylitis following the administration of colchicine. Escalante A; Ehresmann GR; Quismorio FP Arthritis Rheum; 1991 Jul; 34(7):920-2. PubMed ID: 2059239 [TBL] [Abstract][Full Text] [Related]
9. Renal AA amyloidosis in a patient with Bence Jones proteinuria and ankylosing spondylitis. Quinton R; Siersema PD; Michiels JJ; ten Kate FJ J Clin Pathol; 1992 Oct; 45(10):934-6. PubMed ID: 1430270 [TBL] [Abstract][Full Text] [Related]
10. The effect of etanercept on a case of amyloidosis secondary to ankylosing spondylitis: results of 2-year follow-up. Yilmaz H; Kocabas H; Erkin G Acta Reumatol Port; 2013; 38(4):299-301. PubMed ID: 24435036 [TBL] [Abstract][Full Text] [Related]
11. Report on 59 patients with renal amyloidosis. Paydas S Int Urol Nephrol; 1999; 31(5):619-31. PubMed ID: 10755352 [TBL] [Abstract][Full Text] [Related]
12. Colchicine-sensitive nephrotic syndrome due to AA amyloidosis. Hausmann MJ; Maor E; Kachko L Amyloid; 2011 Sep; 18(3):169-71. PubMed ID: 21770831 [TBL] [Abstract][Full Text] [Related]
13. [Effective long-term use of colchicine in secondary AA-amyloidosis]. Rameev VV; Chegaeva TV; Proskurneva EP Ter Arkh; 1999; 71(1):54-7. PubMed ID: 10097303 [No Abstract] [Full Text] [Related]
14. [Renal amyloidosis during Behçet's disease. Study of one case]. Azzabi S; Ben Hassine L; Cherif E; Kooli C; Kaouache Z; Goucha R; Khedher A; Ben Moussa F; Khalfallah N Tunis Med; 2009 Mar; 87(3):213-4. PubMed ID: 19537018 [TBL] [Abstract][Full Text] [Related]
15. Successful use of tocilizumab in a patient with nephrotic syndrome due to a rapidly progressing AA amyloidosis secondary to latent tuberculosis. Magro-Checa C; Navas-Parejo Casado A; Borrego-García E; Raya-Álvarez E; Rosales-Alexander JL; Salvatierra J; Caballero-Morales T; Gómez-Morales M Amyloid; 2011 Dec; 18(4):235-9. PubMed ID: 21992511 [TBL] [Abstract][Full Text] [Related]
16. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. Zemer D; Pras M; Sohar E; Modan M; Cabili S; Gafni J N Engl J Med; 1986 Apr; 314(16):1001-5. PubMed ID: 3515182 [TBL] [Abstract][Full Text] [Related]
17. No regression of renal amyloid mass despite remission of nephrotic syndrome in a patient with TRAPS following etanercept therapy. Simsek I; Kaya A; Erdem H; Pay S; Yenicesu M; Dinc A J Nephrol; 2010; 23(1):119-23. PubMed ID: 20091495 [TBL] [Abstract][Full Text] [Related]